Skip to main content

Nonprofit · EIN 33-2407762

PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION

Tax-exempt · SAN FRANCISCO, CA 94143

Financials

$266K$8K2025
Revenue Expenses · by fiscal year end
Financials of PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$265,592$7,868$257,724$257,724$0$257,724
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$265,592
Program service revenue
$0
Investment income
$0
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Occupancy
$7,500
Management and general (functional)
$7,868

Balance sheet and other

Total assets, start of year
$0
Total assets, end of year
$257,724
Total liabilities, end of year
$0
Net assets, end of year
$257,724
Gross receipts
$265,592
Employees
0
Volunteers
6
Year formed
2024
State of legal domicile
DE

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
CHRISTOPHER DVORAK MDCHAIR
Trustee or director, Officer
1$0
REBECCA MARSH MDSECRETARY
Trustee or director, Officer
1$0
JENNIFER LEIDING MDTREASURER
Trustee or director, Officer
1$0
TROY TORGERSON MDMEMBER
Trustee or director
1$0
MICHAEL PULSIPHER MDMEMBER
Trustee or director
1$0
AMANDA ZABLOCKI JDMEMBER
Trustee or director
1$0

Address and contacts

Address (IRS master file)
550 16TH STREET 4TH FLOOR, SAN FRANCISCO, CA 94143-2549
In care of
% CHRISTOPHER DVORAK
Mailing address (990-N for 2024)
550 16th Street, San Francisco CA 94143
Principal officer (990 for 2025)
CHRISTOPHER DVORAK MD, 550 16TH STREET 4TH FLOOR, SAN FRANCISCO, CA 94143
Principal officer (990-N for 2024)
Christopher C Dvorak, 550 16th Street, San Francisco CA 94143
Signed the 990
CHRISTOPHER DVORAK MD, CHAIR
Phone
(727) 251-9102
Return prepared by
RIVERO GORDIMER & COMPANY PA

California records

California keeps its own records of charities and corporations. Search them by EIN 33-2407762 or by the name PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

THE ORGANIZATION IS A NIH FUNDED CONSORTIUM CONDUCTING MEDICAL RESEARCH TO UNDERSTAND HOW TO BEST TREAT IMMUNE DISORDERS. OUR MISSION IS "WORKING TOGETHER TO IMPROVE THE OUTCOME FOR PATIENTS WITH RARE, LIFE-THREATENING, INHERITED DISORDERS OF THE IMMUNE SYSTEM."

990 for the year ended December 31, 2025

Program accomplishments

  • THE PIDTC IS AN NIH FUNDED RESEARCH CONSORTIUM MADE UP OF 47 INSTITUTIONS IN NORTH AMERICA. THE PIDTC DEVELOPS AND EXECUTES OBSERVATIONAL AND INTERVENTIONAL CLINICAL TRIALS TO UNDERSTAND BEST THERAPIES FOR PATIENTS WITH RARE, LIFE-THREATENING, INHERITED DISORDERS OF THE IMMUNE SYSTEM. IN ADDITON, THE PIDTC HOLDS AN ANNUAL MEETING EACH YEAR WHERE INVESTIGATORS AND TRAINEES FROM ALL 47 CENTERS MEET. AS PART OF THE ANNUAL MEETING, WE ALSO CONDUCT AN EDUCATION DAY WHERE MEDICAL STUDENTS, RESIDENTS, AND FELLOWS CAN ATTEND TO LEARN MORE ABOUT TREATMENT OF PATIENTS WITH INBORN ERRORS OF IMMUNITY.

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990-N on file
2023December 31, 2023May 15, 2024Check at the IRS

IRS record

EIN
33-2407762
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2025
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Health care (E12)
Assets (IRS master file)
$257,724
Income (IRS master file)
$265,592

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$265,592$7,868$257,724IRS
990-N for 2024
Officer: Christopher C Dvorak
December 31, 2024≤ $50,000 receipts––e-Postcard

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 33-2407762).

Questions about PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION

What is the EIN of PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION?
The employer identification number (EIN) of PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION is 33-2407762.
Is PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2025.
Are donations to PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION?
The 990 for the year ended December 31, 2025 names CHRISTOPHER DVORAK MD.
Who are the officers and directors of PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION?
The 990 for the year ended December 31, 2025 lists 6 people; 0 received compensation from the organization.
How much revenue does PRIMARY IMMUNODEFICIENCY TREATMENT FOUNDATION have?
On its 990 for the year ended December 31, 2025 it reported revenue of $265,592, expenses of $7,868 and total assets of $257,724 at year end.

Other nonprofits in SAN FRANCISCO

All nonprofits in SAN FRANCISCO · California · Health care